VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 23 filers reported holding VERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,281,708 | +49618.1% | 453,689 | -76.0% | 0.00% | -50.0% |
| Q1 2023 | $14,646 | -31.7% | 1,887,351 | +70.2% | 0.01% | -33.3% |
| Q4 2022 | $21,452 | -99.7% | 1,108,649 | +179.3% | 0.01% | +140.0% |
| Q3 2022 | $8,459,000 | +125.0% | 396,928 | +43.7% | 0.01% | +150.0% |
| Q2 2022 | $3,760,000 | +19.9% | 276,243 | +106.9% | 0.00% | 0.0% |
| Q1 2022 | $3,136,000 | +190.6% | 133,500 | +63.9% | 0.00% | +100.0% |
| Q2 2021 | $1,079,000 | – | 81,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
| COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
| Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
| Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
| Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
| Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
| Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |